SCHEMBL26080438

SCHEMBL26080438

c1ccc(-c2cccc(-c3ccc(-c4nc(-c5ccc6sc7ccccc7c6c5)nc(-c5cccc6sc7ccccc7c56)n4)cc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.40
LIMK1 P53667 1/20 0.36
ALOX5 P09917 1/20 0.35
CYP1A2 P05177 1/20 0.34
ROCK1 Q13464 1/20 0.34
GPR3 P46089 1/20 0.34
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 2/20 0.33
F9 P00740 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA2B P29275 1/20 0.33
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25944421 0.99 PIM3 (0.41) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL25950494 0.99 PIM3 (0.41) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL22876157 0.98 PIM3 (0.40) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL19802678 0.98 PIM3 (0.40) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL21149233 0.97 PIM3 (0.39) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL25730550 0.96 ALOX5 (0.37) PIM3LIMK1ALOX5CYP1A2GPR3
SCHEMBL26080448 0.95 PIM3 (0.39) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL21148734 0.95 PIM3 (0.40) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL21149142 0.95 PIM3 (0.38) PIM3LIMK1ALOX5CYP1A2ROCK1
SCHEMBL21148571 0.95 PIM3 (0.40) PIM3LIMK1ALOX5CYP1A2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 PIM3 2808/4885LIMK1 279/4885ALOX5 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.